nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCB1—ovarian cancer	0.249	1	CbGaD
Sumatriptan—SLCO1A2—Chlorambucil—ovarian cancer	0.187	0.348	CbGbCtD
Sumatriptan—ABCG2—Topotecan—ovarian cancer	0.0973	0.181	CbGbCtD
Sumatriptan—ABCG2—Paclitaxel—ovarian cancer	0.0481	0.0895	CbGbCtD
Sumatriptan—ABCG2—Carboplatin—ovarian cancer	0.0453	0.0843	CbGbCtD
Sumatriptan—ABCB1—Topotecan—ovarian cancer	0.0351	0.0652	CbGbCtD
Sumatriptan—ABCG2—Docetaxel—ovarian cancer	0.0348	0.0647	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—ovarian cancer	0.0259	0.0483	CbGbCtD
Sumatriptan—ABCB1—Vinorelbine—ovarian cancer	0.0247	0.0459	CbGbCtD
Sumatriptan—ABCB1—Paclitaxel—ovarian cancer	0.0174	0.0323	CbGbCtD
Sumatriptan—ABCB1—Docetaxel—ovarian cancer	0.0126	0.0233	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—ovarian cancer	0.00936	0.0174	CbGbCtD
Sumatriptan—Melatonin—CYP1B1—ovarian cancer	0.00104	0.498	CrCbGaD
Sumatriptan—Melatonin—ESR1—ovarian cancer	0.000702	0.337	CrCbGaD
Sumatriptan—Eletriptan—ABCB1—ovarian cancer	0.000344	0.165	CrCbGaD
Sumatriptan—MAOA—myometrium—ovarian cancer	0.000225	0.0494	CbGeAlD
Sumatriptan—MAOA—embryo—ovarian cancer	0.000217	0.0475	CbGeAlD
Sumatriptan—SLCO1B1—female reproductive system—ovarian cancer	0.000206	0.0452	CbGeAlD
Sumatriptan—ABCG2—myometrium—ovarian cancer	0.000195	0.0428	CbGeAlD
Sumatriptan—HTR1B—female reproductive system—ovarian cancer	0.000178	0.0391	CbGeAlD
Sumatriptan—MAOA—uterine cervix—ovarian cancer	0.000175	0.0385	CbGeAlD
Sumatriptan—HTR1D—female reproductive system—ovarian cancer	0.000172	0.0378	CbGeAlD
Sumatriptan—MAOA—decidua—ovarian cancer	0.000167	0.0366	CbGeAlD
Sumatriptan—MAOA—endometrium—ovarian cancer	0.000158	0.0348	CbGeAlD
Sumatriptan—ABCG2—uterine cervix—ovarian cancer	0.000152	0.0333	CbGeAlD
Sumatriptan—MAOA—uterus—ovarian cancer	0.000146	0.032	CbGeAlD
Sumatriptan—ABCG2—decidua—ovarian cancer	0.000145	0.0318	CbGeAlD
Sumatriptan—ABCG2—endometrium—ovarian cancer	0.000137	0.0301	CbGeAlD
Sumatriptan—SLCO1A2—testis—ovarian cancer	0.000135	0.0297	CbGeAlD
Sumatriptan—MAOA—female reproductive system—ovarian cancer	0.000131	0.0288	CbGeAlD
Sumatriptan—ABCG2—uterus—ovarian cancer	0.000127	0.0278	CbGeAlD
Sumatriptan—MAOA—female gonad—ovarian cancer	0.000119	0.0262	CbGeAlD
Sumatriptan—MAOA—vagina—ovarian cancer	0.000119	0.0261	CbGeAlD
Sumatriptan—Anaemia—Docetaxel—ovarian cancer	0.000112	0.00054	CcSEcCtD
Sumatriptan—Pancytopenia—Epirubicin—ovarian cancer	0.000111	0.000538	CcSEcCtD
Sumatriptan—Gastritis—Doxorubicin—ovarian cancer	0.000111	0.000536	CcSEcCtD
Sumatriptan—Vomiting—Vinorelbine—ovarian cancer	0.00011	0.000532	CcSEcCtD
Sumatriptan—Dysuria—Epirubicin—ovarian cancer	0.00011	0.000529	CcSEcCtD
Sumatriptan—Rash—Vinorelbine—ovarian cancer	0.000109	0.000528	CcSEcCtD
Sumatriptan—Dermatitis—Vinorelbine—ovarian cancer	0.000109	0.000527	CcSEcCtD
Sumatriptan—Abdominal distension—Doxorubicin—ovarian cancer	0.000109	0.000527	CcSEcCtD
Sumatriptan—Hypotension—Paclitaxel—ovarian cancer	0.000109	0.000526	CcSEcCtD
Sumatriptan—Headache—Vinorelbine—ovarian cancer	0.000109	0.000524	CcSEcCtD
Sumatriptan—Syncope—Docetaxel—ovarian cancer	0.000109	0.000524	CcSEcCtD
Sumatriptan—Influenza—Doxorubicin—ovarian cancer	0.000108	0.000524	CcSEcCtD
Sumatriptan—Asthma—Doxorubicin—ovarian cancer	0.000108	0.000524	CcSEcCtD
Sumatriptan—Dysphagia—Doxorubicin—ovarian cancer	0.000108	0.000524	CcSEcCtD
Sumatriptan—Pollakiuria—Epirubicin—ovarian cancer	0.000108	0.000523	CcSEcCtD
Sumatriptan—ABCG2—bone marrow—ovarian cancer	0.000107	0.0236	CbGeAlD
Sumatriptan—Palpitations—Docetaxel—ovarian cancer	0.000107	0.000517	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000107	0.000517	CcSEcCtD
Sumatriptan—Weight increased—Epirubicin—ovarian cancer	0.000107	0.000515	CcSEcCtD
Sumatriptan—Loss of consciousness—Docetaxel—ovarian cancer	0.000106	0.000514	CcSEcCtD
Sumatriptan—Pancreatitis—Doxorubicin—ovarian cancer	0.000106	0.000513	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000106	0.000513	CcSEcCtD
Sumatriptan—Weight decreased—Epirubicin—ovarian cancer	0.000106	0.000512	CcSEcCtD
Sumatriptan—MAOA—testis—ovarian cancer	0.000106	0.0233	CbGeAlD
Sumatriptan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000106	0.000511	CcSEcCtD
Sumatriptan—Cough—Docetaxel—ovarian cancer	0.000106	0.00051	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—ovarian cancer	0.000106	0.00051	CcSEcCtD
Sumatriptan—Convulsion—Docetaxel—ovarian cancer	0.000105	0.000507	CcSEcCtD
Sumatriptan—DRD2—testis—ovarian cancer	0.000105	0.023	CbGeAlD
Sumatriptan—Paraesthesia—Paclitaxel—ovarian cancer	0.000105	0.000506	CcSEcCtD
Sumatriptan—Hypertension—Docetaxel—ovarian cancer	0.000104	0.000505	CcSEcCtD
Sumatriptan—Drowsiness—Epirubicin—ovarian cancer	0.000104	0.000505	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—ovarian cancer	0.000104	0.000504	CcSEcCtD
Sumatriptan—Dyspnoea—Paclitaxel—ovarian cancer	0.000104	0.000502	CcSEcCtD
Sumatriptan—Somnolence—Paclitaxel—ovarian cancer	0.000104	0.0005	CcSEcCtD
Sumatriptan—ABCG2—female gonad—ovarian cancer	0.000104	0.0227	CbGeAlD
Sumatriptan—Arthralgia—Docetaxel—ovarian cancer	0.000103	0.000498	CcSEcCtD
Sumatriptan—Chest pain—Docetaxel—ovarian cancer	0.000103	0.000498	CcSEcCtD
Sumatriptan—Myalgia—Docetaxel—ovarian cancer	0.000103	0.000498	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—ovarian cancer	0.000103	0.000497	CcSEcCtD
Sumatriptan—ABCG2—vagina—ovarian cancer	0.000103	0.0226	CbGeAlD
Sumatriptan—Nausea—Vinorelbine—ovarian cancer	0.000103	0.000497	CcSEcCtD
Sumatriptan—Conjunctivitis—Epirubicin—ovarian cancer	0.000102	0.000491	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—ovarian cancer	0.000101	0.00049	CcSEcCtD
Sumatriptan—Decreased appetite—Paclitaxel—ovarian cancer	0.000101	0.000489	CcSEcCtD
Sumatriptan—Dry mouth—Docetaxel—ovarian cancer	0.000101	0.000487	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000101	0.000486	CcSEcCtD
Sumatriptan—Fatigue—Paclitaxel—ovarian cancer	0.0001	0.000485	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—ovarian cancer	0.0001	0.000484	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—ovarian cancer	0.0001	0.000484	CcSEcCtD
Sumatriptan—Pain—Paclitaxel—ovarian cancer	9.97e-05	0.000481	CcSEcCtD
Sumatriptan—Constipation—Paclitaxel—ovarian cancer	9.97e-05	0.000481	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—ovarian cancer	9.96e-05	0.000481	CcSEcCtD
Sumatriptan—Confusional state—Docetaxel—ovarian cancer	9.96e-05	0.000481	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—ovarian cancer	9.89e-05	0.000478	CcSEcCtD
Sumatriptan—Anaphylactic shock—Docetaxel—ovarian cancer	9.88e-05	0.000477	CcSEcCtD
Sumatriptan—Oedema—Docetaxel—ovarian cancer	9.88e-05	0.000477	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—ovarian cancer	9.87e-05	0.000477	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—ovarian cancer	9.85e-05	0.000476	CcSEcCtD
Sumatriptan—Infection—Docetaxel—ovarian cancer	9.81e-05	0.000474	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—ovarian cancer	9.81e-05	0.000474	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—ovarian cancer	9.8e-05	0.000473	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—ovarian cancer	9.78e-05	0.000472	CcSEcCtD
Sumatriptan—Shock—Docetaxel—ovarian cancer	9.72e-05	0.000469	CcSEcCtD
Sumatriptan—Nervous system disorder—Docetaxel—ovarian cancer	9.69e-05	0.000468	CcSEcCtD
Sumatriptan—Thrombocytopenia—Docetaxel—ovarian cancer	9.67e-05	0.000467	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—ovarian cancer	9.67e-05	0.000467	CcSEcCtD
Sumatriptan—Tachycardia—Docetaxel—ovarian cancer	9.64e-05	0.000466	CcSEcCtD
Sumatriptan—ABCB1—myometrium—ovarian cancer	9.63e-05	0.0211	CbGeAlD
Sumatriptan—Feeling abnormal—Paclitaxel—ovarian cancer	9.6e-05	0.000464	CcSEcCtD
Sumatriptan—Skin disorder—Docetaxel—ovarian cancer	9.59e-05	0.000464	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—ovarian cancer	9.55e-05	0.000461	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Paclitaxel—ovarian cancer	9.53e-05	0.00046	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—ovarian cancer	9.42e-05	0.000455	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—ovarian cancer	9.39e-05	0.000454	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—ovarian cancer	9.38e-05	0.000453	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—ovarian cancer	9.33e-05	0.000451	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—ovarian cancer	9.27e-05	0.000448	CcSEcCtD
Sumatriptan—ABCB1—embryo—ovarian cancer	9.26e-05	0.0203	CbGeAlD
Sumatriptan—Urticaria—Paclitaxel—ovarian cancer	9.26e-05	0.000447	CcSEcCtD
Sumatriptan—Hypotension—Docetaxel—ovarian cancer	9.23e-05	0.000446	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—ovarian cancer	9.22e-05	0.000445	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—ovarian cancer	9.21e-05	0.000445	CcSEcCtD
Sumatriptan—Abdominal pain—Paclitaxel—ovarian cancer	9.21e-05	0.000445	CcSEcCtD
Sumatriptan—Body temperature increased—Paclitaxel—ovarian cancer	9.21e-05	0.000445	CcSEcCtD
Sumatriptan—ABCG2—testis—ovarian cancer	9.19e-05	0.0202	CbGeAlD
Sumatriptan—Epistaxis—Doxorubicin—ovarian cancer	9.12e-05	0.00044	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—ovarian cancer	9.07e-05	0.000438	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—ovarian cancer	9.04e-05	0.000437	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9e-05	0.000435	CcSEcCtD
Sumatriptan—Paraesthesia—Docetaxel—ovarian cancer	8.87e-05	0.000428	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—ovarian cancer	8.83e-05	0.000427	CcSEcCtD
Sumatriptan—Dyspnoea—Docetaxel—ovarian cancer	8.81e-05	0.000425	CcSEcCtD
Sumatriptan—Somnolence—Docetaxel—ovarian cancer	8.78e-05	0.000424	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—ovarian cancer	8.76e-05	0.000423	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—ovarian cancer	8.74e-05	0.000422	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—ovarian cancer	8.72e-05	0.000421	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—ovarian cancer	8.7e-05	0.00042	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—ovarian cancer	8.68e-05	0.000419	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—ovarian cancer	8.63e-05	0.000417	CcSEcCtD
Sumatriptan—Decreased appetite—Docetaxel—ovarian cancer	8.59e-05	0.000415	CcSEcCtD
Sumatriptan—Hypersensitivity—Paclitaxel—ovarian cancer	8.59e-05	0.000415	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Docetaxel—ovarian cancer	8.53e-05	0.000412	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—ovarian cancer	8.53e-05	0.000412	CcSEcCtD
Sumatriptan—Fatigue—Docetaxel—ovarian cancer	8.52e-05	0.000411	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—ovarian cancer	8.51e-05	0.000411	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—ovarian cancer	8.47e-05	0.000409	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—ovarian cancer	8.45e-05	0.000408	CcSEcCtD
Sumatriptan—Pain—Docetaxel—ovarian cancer	8.45e-05	0.000408	CcSEcCtD
Sumatriptan—Constipation—Docetaxel—ovarian cancer	8.45e-05	0.000408	CcSEcCtD
Sumatriptan—Chills—Epirubicin—ovarian cancer	8.41e-05	0.000406	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—ovarian cancer	8.38e-05	0.000405	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—ovarian cancer	8.36e-05	0.000404	CcSEcCtD
Sumatriptan—Asthenia—Paclitaxel—ovarian cancer	8.36e-05	0.000404	CcSEcCtD
Sumatriptan—Pruritus—Paclitaxel—ovarian cancer	8.24e-05	0.000398	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—ovarian cancer	8.16e-05	0.000394	CcSEcCtD
Sumatriptan—Feeling abnormal—Docetaxel—ovarian cancer	8.14e-05	0.000393	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—ovarian cancer	8.11e-05	0.000392	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—ovarian cancer	8.09e-05	0.000391	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Docetaxel—ovarian cancer	8.08e-05	0.00039	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—ovarian cancer	8.05e-05	0.000389	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—ovarian cancer	8.04e-05	0.000389	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—ovarian cancer	7.99e-05	0.000386	CcSEcCtD
Sumatriptan—Diarrhoea—Paclitaxel—ovarian cancer	7.97e-05	0.000385	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—ovarian cancer	7.9e-05	0.000381	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—ovarian cancer	7.87e-05	0.00038	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—ovarian cancer	7.85e-05	0.000379	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—ovarian cancer	7.84e-05	0.000379	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—ovarian cancer	7.82e-05	0.000378	CcSEcCtD
Sumatriptan—Abdominal pain—Docetaxel—ovarian cancer	7.81e-05	0.000377	CcSEcCtD
Sumatriptan—Body temperature increased—Docetaxel—ovarian cancer	7.81e-05	0.000377	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—ovarian cancer	7.79e-05	0.000376	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—ovarian cancer	7.75e-05	0.000374	CcSEcCtD
Sumatriptan—Dizziness—Paclitaxel—ovarian cancer	7.71e-05	0.000372	CcSEcCtD
Sumatriptan—MAOA—lymph node—ovarian cancer	7.68e-05	0.0169	CbGeAlD
Sumatriptan—Ill-defined disorder—Epirubicin—ovarian cancer	7.57e-05	0.000366	CcSEcCtD
Sumatriptan—ABCB1—epithelium—ovarian cancer	7.55e-05	0.0166	CbGeAlD
Sumatriptan—Erythema—Doxorubicin—ovarian cancer	7.55e-05	0.000365	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—ovarian cancer	7.54e-05	0.000365	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—ovarian cancer	7.5e-05	0.000362	CcSEcCtD
Sumatriptan—ABCB1—uterine cervix—ovarian cancer	7.49e-05	0.0164	CbGeAlD
Sumatriptan—Flatulence—Doxorubicin—ovarian cancer	7.44e-05	0.00036	CcSEcCtD
Sumatriptan—Vomiting—Paclitaxel—ovarian cancer	7.41e-05	0.000358	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—ovarian cancer	7.4e-05	0.000357	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—ovarian cancer	7.36e-05	0.000356	CcSEcCtD
Sumatriptan—Rash—Paclitaxel—ovarian cancer	7.35e-05	0.000355	CcSEcCtD
Sumatriptan—Dermatitis—Paclitaxel—ovarian cancer	7.34e-05	0.000355	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—ovarian cancer	7.33e-05	0.000354	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—ovarian cancer	7.32e-05	0.000354	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—ovarian cancer	7.31e-05	0.000353	CcSEcCtD
Sumatriptan—Headache—Paclitaxel—ovarian cancer	7.3e-05	0.000353	CcSEcCtD
Sumatriptan—Hypersensitivity—Docetaxel—ovarian cancer	7.28e-05	0.000352	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—ovarian cancer	7.26e-05	0.000351	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—ovarian cancer	7.21e-05	0.000349	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—ovarian cancer	7.17e-05	0.000347	CcSEcCtD
Sumatriptan—ABCB1—decidua—ovarian cancer	7.14e-05	0.0157	CbGeAlD
Sumatriptan—Cough—Epirubicin—ovarian cancer	7.12e-05	0.000344	CcSEcCtD
Sumatriptan—Asthenia—Docetaxel—ovarian cancer	7.09e-05	0.000342	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—ovarian cancer	7.07e-05	0.000342	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—ovarian cancer	7.05e-05	0.00034	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—ovarian cancer	7.01e-05	0.000339	CcSEcCtD
Sumatriptan—Pruritus—Docetaxel—ovarian cancer	6.99e-05	0.000338	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—ovarian cancer	6.98e-05	0.000337	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—ovarian cancer	6.95e-05	0.000336	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—ovarian cancer	6.95e-05	0.000336	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—ovarian cancer	6.95e-05	0.000336	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—ovarian cancer	6.94e-05	0.000335	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—ovarian cancer	6.93e-05	0.000335	CcSEcCtD
Sumatriptan—Nausea—Paclitaxel—ovarian cancer	6.92e-05	0.000334	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—ovarian cancer	6.87e-05	0.000332	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—ovarian cancer	6.81e-05	0.000329	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—ovarian cancer	6.8e-05	0.000328	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—ovarian cancer	6.79e-05	0.000328	CcSEcCtD
Sumatriptan—ABCB1—endometrium—ovarian cancer	6.77e-05	0.0149	CbGeAlD
Sumatriptan—Syncope—Doxorubicin—ovarian cancer	6.77e-05	0.000327	CcSEcCtD
Sumatriptan—Diarrhoea—Docetaxel—ovarian cancer	6.76e-05	0.000326	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—ovarian cancer	6.72e-05	0.000325	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—ovarian cancer	6.67e-05	0.000322	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—ovarian cancer	6.66e-05	0.000322	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—ovarian cancer	6.66e-05	0.000322	CcSEcCtD
Sumatriptan—ABCG2—lymph node—ovarian cancer	6.66e-05	0.0146	CbGeAlD
Sumatriptan—Loss of consciousness—Doxorubicin—ovarian cancer	6.64e-05	0.000321	CcSEcCtD
Sumatriptan—Infection—Epirubicin—ovarian cancer	6.62e-05	0.00032	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—ovarian cancer	6.59e-05	0.000318	CcSEcCtD
Sumatriptan—Shock—Epirubicin—ovarian cancer	6.55e-05	0.000317	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—ovarian cancer	6.54e-05	0.000316	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—ovarian cancer	6.53e-05	0.000316	CcSEcCtD
Sumatriptan—Dizziness—Docetaxel—ovarian cancer	6.53e-05	0.000316	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—ovarian cancer	6.52e-05	0.000315	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—ovarian cancer	6.52e-05	0.000315	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—ovarian cancer	6.5e-05	0.000314	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—ovarian cancer	6.47e-05	0.000313	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—ovarian cancer	6.44e-05	0.000311	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—ovarian cancer	6.43e-05	0.000311	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—ovarian cancer	6.43e-05	0.000311	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—ovarian cancer	6.43e-05	0.000311	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—ovarian cancer	6.41e-05	0.00031	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—ovarian cancer	6.35e-05	0.000307	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—ovarian cancer	6.29e-05	0.000304	CcSEcCtD
Sumatriptan—ABCB1—gonad—ovarian cancer	6.28e-05	0.0138	CbGeAlD
Sumatriptan—Vomiting—Docetaxel—ovarian cancer	6.28e-05	0.000303	CcSEcCtD
Sumatriptan—ABCB1—uterus—ovarian cancer	6.24e-05	0.0137	CbGeAlD
Sumatriptan—Rash—Docetaxel—ovarian cancer	6.23e-05	0.000301	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—ovarian cancer	6.23e-05	0.000301	CcSEcCtD
Sumatriptan—Dermatitis—Docetaxel—ovarian cancer	6.22e-05	0.000301	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—ovarian cancer	6.22e-05	0.0003	CcSEcCtD
Sumatriptan—Headache—Docetaxel—ovarian cancer	6.19e-05	0.000299	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—ovarian cancer	6.16e-05	0.000298	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—ovarian cancer	6.16e-05	0.000298	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—ovarian cancer	6.12e-05	0.000296	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.07e-05	0.000293	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—ovarian cancer	6.06e-05	0.000293	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—ovarian cancer	6.05e-05	0.000292	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—ovarian cancer	6.04e-05	0.000292	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—ovarian cancer	6.02e-05	0.000291	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—ovarian cancer	5.99e-05	0.000289	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—ovarian cancer	5.98e-05	0.000289	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—ovarian cancer	5.96e-05	0.000288	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—ovarian cancer	5.94e-05	0.000287	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—ovarian cancer	5.92e-05	0.000286	CcSEcCtD
Sumatriptan—Nausea—Docetaxel—ovarian cancer	5.87e-05	0.000283	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—ovarian cancer	5.79e-05	0.00028	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—ovarian cancer	5.76e-05	0.000278	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—ovarian cancer	5.75e-05	0.000278	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—ovarian cancer	5.74e-05	0.000277	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—ovarian cancer	5.7e-05	0.000275	CcSEcCtD
Sumatriptan—Pain—Epirubicin—ovarian cancer	5.7e-05	0.000275	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	5.62e-05	0.000271	CcSEcCtD
Sumatriptan—ABCB1—female reproductive system—ovarian cancer	5.61e-05	0.0123	CbGeAlD
Sumatriptan—Paraesthesia—Doxorubicin—ovarian cancer	5.54e-05	0.000267	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—ovarian cancer	5.5e-05	0.000266	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—ovarian cancer	5.49e-05	0.000265	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—ovarian cancer	5.48e-05	0.000265	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—ovarian cancer	5.45e-05	0.000263	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—ovarian cancer	5.36e-05	0.000259	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.32e-05	0.000257	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—ovarian cancer	5.31e-05	0.000257	CcSEcCtD
Sumatriptan—ABCB1—bone marrow—ovarian cancer	5.3e-05	0.0116	CbGeAlD
Sumatriptan—Urticaria—Epirubicin—ovarian cancer	5.29e-05	0.000256	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—ovarian cancer	5.27e-05	0.000255	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—ovarian cancer	5.27e-05	0.000255	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—ovarian cancer	5.27e-05	0.000254	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—ovarian cancer	5.27e-05	0.000254	CcSEcCtD
Sumatriptan—ABCB1—female gonad—ovarian cancer	5.11e-05	0.0112	CbGeAlD
Sumatriptan—Feeling abnormal—Doxorubicin—ovarian cancer	5.08e-05	0.000245	CcSEcCtD
Sumatriptan—ABCB1—vagina—ovarian cancer	5.08e-05	0.0111	CbGeAlD
Sumatriptan—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.04e-05	0.000244	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—ovarian cancer	4.91e-05	0.000237	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—ovarian cancer	4.9e-05	0.000237	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—ovarian cancer	4.87e-05	0.000235	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—ovarian cancer	4.87e-05	0.000235	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—ovarian cancer	4.78e-05	0.000231	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—ovarian cancer	4.71e-05	0.000228	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—ovarian cancer	4.56e-05	0.00022	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—ovarian cancer	4.54e-05	0.000219	CcSEcCtD
Sumatriptan—ABCB1—testis—ovarian cancer	4.53e-05	0.00994	CbGeAlD
Sumatriptan—Asthenia—Doxorubicin—ovarian cancer	4.42e-05	0.000214	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—ovarian cancer	4.41e-05	0.000213	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—ovarian cancer	4.36e-05	0.000211	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—ovarian cancer	4.24e-05	0.000205	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—ovarian cancer	4.22e-05	0.000204	CcSEcCtD
Sumatriptan—Rash—Epirubicin—ovarian cancer	4.2e-05	0.000203	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—ovarian cancer	4.2e-05	0.000203	CcSEcCtD
Sumatriptan—Headache—Epirubicin—ovarian cancer	4.17e-05	0.000202	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—ovarian cancer	4.08e-05	0.000197	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—ovarian cancer	3.96e-05	0.000191	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—ovarian cancer	3.92e-05	0.000189	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—ovarian cancer	3.89e-05	0.000188	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—ovarian cancer	3.88e-05	0.000188	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—ovarian cancer	3.86e-05	0.000187	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—ovarian cancer	3.66e-05	0.000177	CcSEcCtD
Sumatriptan—ABCB1—lymph node—ovarian cancer	3.28e-05	0.0072	CbGeAlD
